The summer 2024 COVID-19 wave is a good reminder that it’s important to get vaccinated with the updated shot.
Academic rigor, journalistic flair
Articles on RSV vaccine
Displaying all articles
The vaccine protects newborn babies through antibodies that cross the placenta.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
Newly approved and updated vaccines are the best tools available to combat COVID-19, the flu and RSV, as infections and hospitalizations tick upward and cold and flu season gets underway.
Nearly 100,000 US children under age 5 are hospitalized each year for an RSV infection.
Even otherwise healthy children can end up in hospital with this winter respiratory virus.
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Top contributors
-
Associate Professor of Epidemiology, University of San Francisco
-
Professor of Infectious Diseases, Monash University
-
Paediatric Respiratory Physician, and Honorary Fellow Manager, Murdoch Children's Research Institute
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Professor of Nursing, Purdue University
-
Senior Research Officer, Murdoch Children's Research Institute
-
Research Nurse Coordinator, Murdoch Children's Research Institute
-
Professor, Department of Infectious Diseases, The University of Melbourne
-
Associate Professor of Pediatric Infectious Diseases, Baylor College of Medicine
